Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
SiTime
SITM
$20.5B
| $45.8M | 0.01% |
224,514
-551
| -0.2% | -$98.3K |
|
1352
Cardlytics
CDLX
$24.7M
| $45.8M | 0.01% |
54,542
-667
| -1% | -$677K |
|
|
AMRS
1353
DELISTED
Amyris Inc.
AMRS
| $45.8M | 0.01% |
3,333,551
+83,539
| +3% | +$1.2M |
|
1354
Ingevity
NGVT
$2.62B
| $45.6M | 0.01% |
639,170
-23,310
| -4% | -$1.84M |
|
|
OCDX
1355
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $45.6M | 0.01% |
2,468,318
+960,962
| +64% | +$19.3M |
|
1356
Domo
DOMO
$184M
| $45.6M | 0.01% |
540,105
+2,314
| +0.4% | +$198K |
|
1357
Hyatt Hotels
H
$16.8B
| $45.5M | 0.01% |
589,806
-67,769
| -10% | -$5.11M |
|
1358
Newmark Group
NMRK
$2.63B
| $45.5M | 0.01% |
3,176,552
-391,802
| -11% | -$5.05M |
|
1359
National Health Investors
NHI
$3.47B
| $45.5M | 0.01% |
849,559
-35,157
| -4% | -$2.2M |
|
1360
Rogers Communications
RCI
$19.4B
| $45.4M | 0.01% |
961,315
+86,637
| +10% | +$4.36M |
|
1361
Helios Technologies
HLIO
$2.67B
| $45.4M | 0.01% |
552,801
-5,817
| -1% | -$474K |
|
1362
Dorman Products
DORM
$3.97B
| $45.4M | 0.01% |
479,139
-9,766
| -2% | -$963K |
|
1363
Columbia Sportswear
COLM
$2.88B
| $45.3M | 0.01% |
472,719
+20,268
| +4% | +$2.05M |
|
1364
Vishay Intertechnology
VSH
$5.15B
| $45.3M | 0.01% |
2,254,519
+22,708
| +1% | +$491K |
|
1365
Yelp
YELP
$1.28B
| $45.3M | 0.01% |
1,215,856
-36,888
| -3% | -$1.4M |
|
|
MDLA
1366
DELISTED
Medallia, Inc.
MDLA
| $45.3M | 0.01% |
1,336,272
+268,882
| +25% | +$8.98M |
|
|
BECN
1367
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $45.2M | 0.01% |
946,603
-22,574
| -2% | -$1.17M |
|
1368
MGE Energy Inc
MGEE
$3.07B
| $45.2M | 0.01% |
614,609
-29,120
| -5% | -$2.28M |
|
1369
BioCryst Pharmaceuticals
BCRX
$2.71B
| $45.1M | 0.01% |
3,139,499
+26,937
| +0.9% | +$425K |
|
1370
United Natural Foods
UNFI
$2.9B
| $45.1M | 0.01% |
931,063
-940
| -0.1% | -$33.3K |
|
|
KRTX
1371
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $45.1M | 0.01% |
368,355
+9,384
| +3% | +$1.08M |
|
|
PDM
1372
Piedmont Realty Trust
PDM
$1.19B
| $44.9M | 0.01% |
2,575,445
+110,419
| +4% | +$2.01M |
|
1373
Frontdoor
FTDR
$5.89B
| $44.8M | 0.01% |
1,068,442
-81,380
| -7% | -$3.72M |
|
1374
Evertec
EVTC
$1.82B
| $44.7M | 0.01% |
978,161
-105,720
| -10% | -$4.77M |
|
1375
Qiagen
QGEN
$8.88B
| $44.6M | 0.01% |
814,740
+110,073
| +16% | +$6.13M |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.